BMEZ · BlackRock Health Sciences Term Trust

$16.97 -0.28 (-1.62%) At close · Aug 20

Market Cap

$1.06B

62.50M

Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.

BlackRock Health Sciences Term Trust

Reported 2026-03-31

Net Assets

$1,012,211,808

Total Assets

$1,037,304,742

Holdings

176

Filed

2026-05-28

Holding	CUSIP	Balance	Units	Value	% Net Assets	Category	Country
BlackRock Liquidity Funds	09248U718	48,671,382	NS	$48,671,382	4.81%	STIV	US
Johnson & Johnson	478160104	145,639	NS	$35,599,997	3.52%	EC	US
Merck & Co Inc	58933Y105	262,388	NS	$31,562,653	3.12%	EC	US
Gilead Sciences Inc	375558103	214,745	NS	$29,929,011	2.96%	EC	US
Moderna Inc	60770K107	549,814	NS	$27,930,551	2.76%	EC	US
Biogen Inc	09062X103	137,487	NS	$25,205,492	2.49%	EC	US
PsiQuantum Corp	000000000	571,947	NS	$23,650,008	2.34%	EC	US
Edwards Lifesciences Corp	28176E108	277,879	NS	$22,252,550	2.20%	EC	US
Guardant Health Inc	40131M109	221,348	NS	$20,445,915	2.02%	EC	US
Roche Holding AG	000000000	42,839	NS	$17,096,653	1.69%	EC	CH
Natera Inc	632307104	82,862	NS	$16,571,571	1.64%	EC	US
Novartis AG	000000000	104,397	NS	$16,024,346	1.58%	EC	CH
Amgen Inc	031162100	45,282	NS	$15,932,472	1.57%	EC	US
Genmab A/S	000000000	58,159	NS	$15,663,462	1.55%	EC	DK
Pfizer Inc	717081103	538,786	NS	$15,129,111	1.49%	EC	US
Lonza Group AG	000000000	23,258	NS	$14,920,434	1.47%	EC	CH
GSK PLC	000000000	521,765	NS	$14,372,267	1.42%	EC	GB
Illumina Inc	452327109	116,338	NS	$14,339,822	1.42%	EC	US
UCB SA	000000000	44,287	NS	$13,343,531	1.32%	EC	BE
RENAGADE THERAPEUTICS A 2	000000000	3,584,906	NS	$13,049,058	1.29%	EC	US
AbbVie Inc	00287Y109	59,784	NS	$13,002,422	1.28%	EC	US
Agilent Technologies Inc	00846U101	112,566	NS	$12,830,273	1.27%	EC	US
Sartorius AG	000000000	47,229	NS	$11,817,487	1.17%	EP	DE
AstraZeneca PLC	000000000	57,869	NS	$11,412,924	1.13%	EC	GB
ADARX PHARMACEUTICALS INC	000000000	860,577	NS	$11,282,164	1.11%	EC	US
BlackRock Funds III	066922519	11,103,934	NS	$11,106,155	1.10%	STIV	US
Dexcom Inc	252131107	173,259	NS	$10,880,665	1.07%	EC	US
Intuitive Surgical Inc	46120E602	23,573	NS	$10,866,917	1.07%	EC	US
Bristol-Myers Squibb Co	110122108	177,819	NS	$10,784,722	1.07%	EC	US
Charles River Laboratories International Inc	159864107	60,883	NS	$10,502,318	1.04%	EC	US
Neurocrine Biosciences Inc	64125C109	79,676	NS	$10,496,516	1.04%	EC	US
Hologic Inc	436440101	137,197	NS	$10,370,721	1.02%	EC	US
Bridgebio Pharma Inc	10806X102	136,783	NS	$10,157,506	1.00%	EC	US
Danaher Corp	235851102	53,519	NS	$10,147,202	1.00%	EC	US
Medtronic PLC	000000000	115,270	NS	$9,988,146	0.99%	EC	IE
Immunocore Limited	000000000	321,900	NS	$9,705,285	0.96%	STIV	US
Rhythm Pharmaceuticals Inc	76243J105	111,452	NS	$9,692,980	0.96%	EC	US
Boston Scientific Corp	101137107	154,391	NS	$9,688,035	0.96%	EC	US
Eisai Co Ltd	000000000	304,900	NS	$9,545,445	0.94%	EC	JP
Vertex Pharmaceuticals Inc	92532F100	20,900	NS	$9,332,686	0.92%	EC	US
LARONDE INC	000000000	482,077	NS	$9,313,728	0.92%	EC	US
Exelixis Inc	30161Q104	210,176	NS	$9,014,449	0.89%	EC	US
Bio-Techne Corp	09073M104	169,594	NS	$8,862,982	0.88%	EC	US
Argenx SE	04016X101	11,933	NS	$8,714,073	0.86%	EC	NL
Terns Pharmaceuticals Inc	880881107	155,371	NS	$8,191,159	0.81%	EC	US
NUMAB THERAPEUTICS AG	000000000	1,139,305	NS	$8,107,360	0.80%	EC	CH
IQVIA Holdings Inc	46266C105	46,747	NS	$7,972,233	0.79%	EC	US
KARTOS THERAPEUTICS INC	000000000	1,333,783	NS	$7,575,887	0.75%	STIV	US
GENESIS THERAPEUTICS INC	000000000	1,370,506	NS	$7,496,668	0.74%	EC	US
Protagonist Therapeutics Inc	74366E102	68,855	NS	$7,257,317	0.72%	EC	US

Showing 1–50 of 176 holdings

Key facts CIK 1785971 CUSIP 09260E105 13F (30d) 72 filings 72 filers